Long Covid Treatment Research Study
Researchers at BIDMC are partnering with individuals experiencing Post COVID Condition (PCC)/Long COVID to evaluate the effect of an investigational medication. Join our research study today to help our investigators learn more about treating Long COVID.
Fast Facts
history of confirmed COVID-19 infection
post-COVID symptoms for at least 2 months
18-65 Years Old
Compensation Provided
Conducted in Boston, MA
Study Background
Post COVID Condition (PCC) or “Long COVID”
Some people who have had COVID-19 continue to experience symptoms for a long time after they were first infected. Symptoms might reappear after initial recovery from COVID-19, or they may persist from the initial illness. Symptoms may also fluctuate or stop and start over time. This is commonly known as “Long COVID”.
This research study aims to test the efficacy, safety, and tolerability of an oral medication called abrocitinib to treat Long COVID. Abrocitinib is approved to treat atopic dermatitis (eczema) but is investigational in Long COVID.
Your participation in this study may help researchers improve treatment approaches for Long COVID. Advance research today and join our compensated study!
Study Background
Post COVID Condition (PCC) or “Long COVID”
Some people who have had COVID-19 continue to experience symptoms for a long time after they were first infected. Symptoms might reappear after initial recovery from COVID-19, or they may persist from the initial illness. Symptoms may also fluctuate or stop and start over time. This is commonly known as “Long COVID”.
This research study aims to test the efficacy, safety, and tolerability of an oral medication called abrocitinib to treat Long COVID. Abrocitinib is approved to treat atopic dermatitis (eczema) but is investigational in Long COVID.
Your participation in this study may help researchers improve treatment approaches for Long COVID. Advance research today and join our compensated study!
Additional Information
You may qualify for this study if you meet the following criteria.
Key Criteria:
- 18-65 years old
- History of confirmed COVID-19 infection more than 30 days ago
- Ongoing COVID symptoms for at least 2 months that cannot be explained by another diagnosis. There are many symptoms associated with PCC. This study may be right for you if you are experiencing a post COVID condition of fatigue
- Otherwise generally healthy
- No other acute or chronic infections
- No history of HIV, Hepatitis B, Hepatitis C, herpes, tuberculosis, Epstein Barr Virus, immunodeficiency disorders, cancers, blood clotting disorders, heart conditions, or other chronic conditions that have caused debilitating symptoms
- If a person of childbearing potential, willing to use contraception to prevent pregnancy
- Not currently pregnant or breastfeeding
- Willing and able to come to BIDMC for 6 in-person visits over 4 months
In this study, participants will be asked to fill out questionnaires and there will be urine and blood sample collections at each visit. Each visit will take place in-person, at Beth Israel Deaconess Medical Center in Boston.
